Opus Point Partners Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Opus Point Partners Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-82,430	Closed	-$2.42M	–	46
2018 Q3	$2.42M	Buy	82,430 +69,430	+534%	+$2.69M	5.78%	3
2018 Q2	$591K	Hold	13,000	–	–	1.28%	24
2018 Q1	$686K	Sell	13,000 -2,000	-13%	-$117K	1.35%	25
2017 Q4	$1.02M	Hold	15,000	–	–	0.88%	33
2017 Q3	$1.24M	Hold	15,000	–	–	1.11%	32
2017 Q2	$1.4M	Sell	15,000 -15,000	-50%	-$918K	1.29%	31
2017 Q1	$1.91M	Hold	30,000	–	–	1.42%	29
2016 Q4	$1.33M	Buy	+30,000	New	+$1.06M	1.06%	30
2016 Q2	–	Sell	-75,000	Closed	-$1.44M	–	53
2016 Q1	$1.44M	Buy	75,000 +25,000	+50%	+$529K	1.11%	28
2015 Q4	$1.75M	Sell	50,000 -8,567	-15%	-$552K	1.16%	26
2015 Q3	$5.39M	Buy	58,567 +6,167	+12%	+$534K	2.97%	3
2015 Q2	$4.61M	Sell	52,400 -3,588	-6%	-$307K	3.65%	6
2015 Q1	$4.16M	Buy	55,988 +28,988	+107%	+$2.05M	3.48%	2
2014 Q4	$1.51M	Buy	+27,000	New	+$1.42M	1.5%	26

Other funds holding CLVS

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return